Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05108987 · ClinicalTrials.gov registry record · NA
Exercise and Time of Day in Type 2 Diabetes
A NA study of Diabetes Mellitus, Type 2 and Metabolic Syndrome, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT05108987 is a NA study of Diabetes Mellitus, Type 2 and Metabolic Syndrome that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 30 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05108987, a NA study of Diabetes Mellitus, Type 2 and Metabolic Syndrome, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall purpose of the study is to test the effect of Noom on exercise and diet advice in adults with type 2 diabetes. The overarching hypothesis is that the use of Noom may promote better dietary adherence during an exercise program, thereby promoting greater weight loss and cardiometabolic health compared to lifestyle advice only. In particular, the investigators anticipate that changes in metabolic and vascular insulin sensitivity will correlate with glycemic control and blood pressure changes.
Conditions Studied
Interventions
- BEHAVIORAL Morning Exercise
- BEHAVIORAL Afternoon Exercise
Study Locations (3)
New Jersey
- New Jersey Institute for Food, Nutrition, and Health - New Brunswick
- Robert Wood Johnson University Hospital Clinical Research Center - New Brunswick
- Rutgers University Loree Gymnasium - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-25 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05108987
The ClinicalTrials.gov registry entry for NCT05108987 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Morning Exercise is the first listed.
NCT05108987 reports 3 study locations spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05108987 about?
NCT05108987 is a clinical study titled "Exercise and Time of Day in Type 2 Diabetes". The overall purpose of the study is to test the effect of Noom on exercise and diet advice in adults with type 2 diabetes. The overarching hypothesis is that the use of Noom may promote better dietary adherence during an exercise program, thereby promoting greater weight loss and cardiometabolic hea...
What is the current status of trial NCT05108987?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-25. Estimated completion is 2026-02-28.
What conditions does trial NCT05108987 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Metabolic Syndrome.
What interventions are being tested in trial NCT05108987?
The interventions under investigation include: Morning Exercise (BEHAVIORAL), Afternoon Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05108987?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05108987 being conducted?
This trial has 3 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.